Thermo Fisher Scientific Inc (TMO): Today's Featured Health Services Winner

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Thermo Fisher Scientific ( TMO) pushed the Health Services industry higher today making it today's featured health services winner. The industry as a whole closed the day up 0.7%. By the end of trading, Thermo Fisher Scientific rose $1.17 (1.3%) to $88.96 on light volume. Throughout the day, 1,761,843 shares of Thermo Fisher Scientific exchanged hands as compared to its average daily volume of 2,406,300 shares. The stock ranged in a price between $87.84-$88.99 after having opened the day at $87.85 as compared to the previous trading day's close of $87.79. Other companies within the Health Services industry that increased today were: Stereotaxis ( STXS), up 21.5%, Harvard Bioscience ( HBIO), up 8.2%, UnitedHealth Group ( UNH), up 6.5% and Alliance HealthCare Services ( AIQ), up 6.5%.

Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacture, analysis, discovery, and diagnostics. Thermo Fisher Scientific has a market cap of $31.4 billion and is part of the health care sector. Shares are up 37.6% year to date as of the close of trading on Wednesday. Currently there are 11 analysts that rate Thermo Fisher Scientific a buy, no analysts rate it a sell, and none rate it a hold.

TheStreet Ratings rates Thermo Fisher Scientific as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, increase in net income, revenue growth and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company shows weak operating cash flow.

On the negative front, American Shared Hospital Services ( AMS), down 8.5%, Spherix ( SPEX), down 7.7%, Organovo Holdings ( ONVO), down 7.1% and American Caresource Holdings ( ANCI), down 5.2% , were all laggards within the health services industry with Laboratory Corporation of America Holdings ( LH) being today's health services industry laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

null

More from Markets

Tiffany & Co. Sees a Strong Market in Asia

Tiffany & Co. Sees a Strong Market in Asia

Stocks Lower as Optimism Wanes Over China Trade Talks

Stocks Lower as Optimism Wanes Over China Trade Talks

Imagining the Stock Market in 10 Years

Imagining the Stock Market in 10 Years

Video: Jim Cramer on the Markets, Tiffany, Micron Technology and Union Pacific

Video: Jim Cramer on the Markets, Tiffany, Micron Technology and Union Pacific

Red Robin Slumps After Earnings Miss

Red Robin Slumps After Earnings Miss